Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03227263
Brief Title: BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). (BABH)

First Submitted : July 21, 2017
First Submitted that Met QC Criteria : July 21, 2017
First Posted : July 24, 2017

Last Update Submitted that Met QC Criteria : July 9, 2018
Last Update Posted : July 10, 2018